Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tacrolimus vs Mycophenolate Mofetil in Active Lupus Nephritis
NCT00371319Phase 4Completed
- Sponsor
- Tuen Mun Hospital
- Start
- Sep 2005
- Primary completion
- May 2014
- Modality
- RNA-Targeting Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of tacrolimus in lupus nephritis (LN) (2 arms), sponsored by Tuen Mun Hospital. Primary endpoint: Remission Rate at 6 months. Started Sep 2005; status: completed.
02
Drugs
tacrolimus
03
Conditions
lupus nephritis (LN)
Beyond the preview
Go deeper on NCT00371319.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00371319.